Correlation of seven biological factors (Hsp90a, p53, MDM2, Bcl-2, bax, cytochrome C, and cleaved caspase3) with clinical outcomes of ALK+ anaplastic large-cell lymphoma

Biomedical and Environmental Sciences

Volumn 24, Issue 6, 2011, Pages 630-641

  Li, Hui Ling ^a   Huang, Xue Ping ^a   Zhou, Xin Hua ^a   Ji, Tian Hai ^a   Wu, Zi Qing ^a   Wang, Zhi Qiang ^a   Jiang, Hui Yong ^a   Liu, Fan Rong ^a   Zhao, Tong ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

ALK+ALCL; Apoptosis; Herbimycin A; NPM ALK; Prognostic factors

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; APOPTOSIS REGULATORY PROTEIN; BENZOQUINONE DERIVATIVE; ENZYME INHIBITOR; HERBIMYCIN; MACROCYCLIC LACTAM; P80(NPM ALK) PROTEIN; P80(NPM-ALK) PROTEIN; PROTEIN TYROSINE KINASE; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; CANCER STAGING; CELL SURVIVAL; CHILD; CULTURE TECHNIQUE; DISEASE FREE SURVIVAL; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LARGE CELL LYMPHOMA; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PRESCHOOL CHILD; PROGNOSIS; RETROSPECTIVE STUDY; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BENZOQUINONES; BLOTTING, WESTERN; CELL CULTURE TECHNIQUES; CELL SURVIVAL; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; ENZYME INHIBITORS; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LACTAMS, MACROCYCLIC; LYMPHOMA, LARGE-CELL, ANAPLASTIC; MALE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROTEIN-TYROSINE KINASES; RECEPTOR PROTEIN-TYROSINE KINASES; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84863229619     PISSN: 08953988     EISSN: None     Source Type: Journal    
DOI: 10.3967/0895-3988.2011.06.007     Document Type: Article

References (31)

1. B Falini, MP Martelli Anaplastic large cell lymphoma: changes in the World Health Organization classification and perspectives for targeted therapy Haematologica 94 2009 897 900
2. SW Morris, C Naeve, P Mathew et al. ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK) Oncogene 14 1997 2175 2188 (Pubitemid 27248229)
3. J Duyster, RY Bai, SW Morris Translocations involving anaplastic lymphoma kinase (ALK) Oncogene 20 2001 5623 5637 (Pubitemid 32928102)
4. RY Bai, P Dieter, C Peschel et al. Nucleophosmin-anaplastic lymphoma kinase of large-cell anaplastic lymphoma is a constitutively active tyrosine kinase that utilizes phospholipase C-gamma to mediate its mitogenicity Mol Cell Biol 18 1998 6951 6961 (Pubitemid 28533016)
5. RY Bai, T Ouyang, C Miething et al. Nucleophosmin-anaplastic lymphoma kinase associated with anaplastic large-cell lymphoma activates the phosphatidylinositol 3-kinase/Akt antiapoptotic signaling pathway Blood 96 2000 4319 4327
6. R Chiarle, C Voena, C Ambrogio et al. The anaplastic lymphoma kinase in the pathogenesis of cancer Nat Rev Cancer 8 2008 11 23
7. R Chiarle, WJ Simmons, H Cai et al. Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target Nat Med 11 2005 623 629 (Pubitemid 40868302)
8. B Vogelstein, D Lane, AJ Levine Surfing the p53 network Nature 408 2000 307 310
9. PF Li, R Dietz, R von Harsdorf p53 regulates mitochondrial membrane potential through reactive oxygen species and induces cytochrome c-independent apoptosis blocked by Bcl-2 EMBO J 18 1999 6027 6036 (Pubitemid 29515679)
10. GZ Rassidakis, A Thomaides, S Wang et al. p53 gene mutations are uncommon but p53 is commonly expressed in anaplastic large-cell lymphoma Leukemia 19 2005 1663 1669 (Pubitemid 43090413)
11. JA Schumacher, DK Crockett, KS Elenitoba-Johnson et al. Proteome-wide changes induced by the Hsp90 inhibitor, geldanamycin in anaplastic large cell lymphoma cells Proteomics 7 2007 2603 2616 (Pubitemid 47253819)
12. B Boll, F Eltaib, KS Reiners et al. Heat shock protein 90 inhibitor BIIB021 (CNF2024) depletes NF-kappaB and sensitizes Hodgkin's lymphoma cells for natural killer cell-mediated cytotoxicity Clin Cancer Res 15 2009 5108 5116
13. E Lukasiewicz, K Miekus, J Kijowski et al. High anti tumor activity against rhabdomyosarcoma cells and low normal cells cytotoxicity of heat shock protein 90 inhibitors, with special emphasis on 17-[2-(pyrrolidin-1-yl)ethyl] -aminno-17-demetho-xygeldanamycin J Physiol Pharmacol 60 2009 161 166
14. JM Adams Ways of dying: multiple pathways to apoptosis Genes Dev 17 2003 2481 2495 (Pubitemid 37271417)
15. H Wajant The Fas signaling pathway: more than a paradigm Science 296 2002 1635 1636 (Pubitemid 34579146)
16. DR Green, G Kroemer The pathophysiology of mitochondrial cell death Science 305 2004 626 629 (Pubitemid 39006738)
17. JM Jurgensmeier, Z Xie, Q Deveraux et al. Bax directly induces release of cytochrome c from isolated mitochondria Proc Natl Acad Sci U S A 95 1998 4997 5002 (Pubitemid 28208539)
18. HR Stennicke, JM Jurgensmeier, H Shin et al. Pro-caspase-3 is a major physiologic target of caspase-8 J Biol Chem 273 1998 27084 27090 (Pubitemid 28500413)
19. F Turturro, AY Frist, MD Arnold et al. Biochemical differences between SUDHL-1 and KARPAS 299 cells derived from t(2;5)-positive anaplastic large cell lymphoma are responsible for the different sensitivity to the antiproliferative effect of p27(Kip1) Oncogene 20 2001 4466 4475 (Pubitemid 32772429)
20. G Hubinger, I Scheffrahn, E Muller et al. The tyrosine kinase NPM-ALK, associated with anaplastic large cell lymphoma, binds the intracellular domain of the surface receptor CD30 but is not activated by CD30 stimulation Exp Hematol 27 1999 1796 1805
21. A Galietta, RH Gunby, S Redaelli et al. NPM/ALK binds and phosphorylates the RNA/DNA-binding protein PSF in anaplastic large-cell lymphoma Blood 110 2007 2600 2609 (Pubitemid 47523184)
22. M Shiota, S Nakamura, R Ichinohasama et al. Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity Blood 86 1995 1954 1960
23. Y Ofir-Rosenfeld, K Boggs, D Michael et al. Mdm2 regulates p53 mRNA translation through inhibitory interactions with ribosomal protein L26 Mol Cell 32 2008 180 189
24. E Drakos, V Atsaves, E Schlette et al. The therapeutic potential of p53 reactivation by nutlin-3a in ALK+ anaplastic large cell lymphoma with wild-type or mutated p53 Leukemia 23 2009 2290 2299
25. YX Cui, A Kerby, FK McDuff et al. NPM-ALK inhibits the p53 tumor suppressor pathway in an MDM2 and JNK-dependent manner Blood 113 2009 5217 5227
26. P Bonvini, T Gastaldi, B Falini et al. Nucleophosmin-anaplastic lymphoma kinase (NPM-ALK), a novel Hsp90-client tyrosine kinase: down-regulation of NPM-ALK expression and tyrosine phosphorylation in ALK(+) CD30(+) lymphoma cells by the Hsp90 antagonist 17-allylamino, 17-demethoxygeldanamycin Cancer Res 62 2002 1559 1566 (Pubitemid 34407823)
27. P Bonvini, H Dalla Rosa, N Vignes et al. Ubiquitination and proteasomal degradation of nucleophosmin-anaplastic lymphoma kinase induced by 17-allylamino-demethoxygeldan-amycin: role of the co-chaperone carboxyl heat shock protein 70-interacting protein Cancer Res 64 2004 3256 3264 (Pubitemid 38581430)
28. GZ Rassidakis, AH Sarris, M Herling et al. Differential expression of BCL-2 family proteins in ALK-positive and ALK-negative anaplastic large cell lymphoma of T/null-cell lineage Am J Pathol 159 2001 527 535 (Pubitemid 32751083)
29. GZ Rassidakis, R Lai, TJ McDonnell et al. Overexpression of Mcl-1 in anaplastic large cell lymphoma cell lines and tumors Am J Pathol 160 2002 2309 2310 (Pubitemid 34663421)
30. GZ Rassidakis, D Jones, R Lai et al. BCL-2 family proteins in peripheral T-cell lymphomas: correlation with tumour apoptosis and proliferation J Pathol 200 2003 240 248 (Pubitemid 36748033)
31. JC Rathmell, CB Thompson The central effectors of cell death in the immune system Annu Rev Immunol 17 1999 781 828 (Pubitemid 29241140)